Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Venous Leg Ulcers (Crural Ulcer) - Overview
Venous Leg Ulcers (Crural Ulcer) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Venous Leg Ulcers (Crural Ulcer) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Venous Leg Ulcers (Crural Ulcer) - Companies Involved in Therapeutics Development
Aurealis Therapeutics AG
CardioVascular BioTherapeutics Inc
CytoTools AG
Energenesis Biomedical Co Ltd
FirstString Research Inc
GangaGen Inc
Hypo-Stream Ltd
Ilkos Therapeutics Inc
Mallinckrodt Plc
MediWound Ltd
NovaLead Pharma Pvt Ltd
Promore Pharma AB
QBiotics Ltd
Reponex Pharmaceuticals Aps
Zhittya Genesis Medicine Inc
Venous Leg Ulcers (Crural Ulcer) - Drug Profiles
AUP-16 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cell Therapy to Activate VEGF for Venous Leg Ulcers and Diabetic Foot Ulcers - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CVBT-141 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CVBT-141B - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Venous Leg Ulcers (Crural Ulcer) - Dormant Projects
Venous Leg Ulcers (Crural Ulcer) - Discontinued Products
Venous Leg Ulcers (Crural Ulcer) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Venous Leg Ulcers (Crural Ulcer), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Venous Leg Ulcers (Crural Ulcer), H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by Aurealis Therapeutics AG, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by CardioVascular BioTherapeutics Inc, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by CytoTools AG, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by Energenesis Biomedical Co Ltd, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by FirstString Research Inc, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by GangaGen Inc, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by Hypo-Stream Ltd, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by Ilkos Therapeutics Inc, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by Mallinckrodt Plc, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by MediWound Ltd, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by NovaLead Pharma Pvt Ltd, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by Promore Pharma AB, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by QBiotics Ltd, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by Reponex Pharmaceuticals Aps, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Pipeline by Zhittya Genesis Medicine Inc, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Dormant Projects, H2 2020
Venous Leg Ulcers (Crural Ulcer) - Discontinued Products, H2 2020